Adverse Events

pause halt pause button
Biotech

Daiichi-Merck ph. 3 ADC program on pause after patient deaths

Daiichi and Merck’s phase 3 program for I-DXd has been hit with a hold after an unexpected number of deaths occurred.
Gabrielle Masson Dec 18, 2025 11:22am
Intellia lab coat

Patient dies after receiving Intellia's CRISPR therapy

Nov 7, 2025 5:25am
Make a delay and accumulation of outstanding tasks Full stop

Genfit ends liver failure program over phase 2 safety signal

Sep 22, 2025 5:14am
pause button on blue background

Capsida pauses phase 1 gene therapy trial after child dies

Sep 11, 2025 7:30am
A doctor with a graphic representation of the lungs

Pliant ends lung disease program over rise in adverse events

Jun 30, 2025 4:49am
positive negative up down good bad mixed

Amgen's ph. 3 MariTide studies will ramp up dosing to quell nausea

Jun 24, 2025 9:59am